Peking Union Medical College Hospital
1,354
264
303
236
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.5%
20 terminated/withdrawn out of 1354 trials
92.2%
+5.7% vs industry average
14%
187 trials in Phase 3/4
4%
9 of 236 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1354)
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Role: lead
Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
Role: lead
Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
Role: lead
Adaptive DBS for PD RCT
Role: collaborator
Study on the Diagnostic Cut-off Point of 24-hour Urinary Aldosterone Measured by Liquid Chromatography-Tandem Mass Spectrometry in the Diagnosis of Primary Aldosteronism in the Oral Sodium Loading Test
Role: lead
Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
Role: lead
Online Adaptive Radiotherapy Cervical Cancer With Reduced Margin for Cervical Cancer
Role: lead
Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer
Role: lead
Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia
Role: lead
HAL-PDT for Cervical Intraepithelial Neoplasia Grade 2
Role: lead
Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery
Role: collaborator
Biktarvy in Treatment-Naïve Late Presenters With HIV-1 Infection
Role: lead
Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA
Role: lead
Multicenter Registry Study of Patients With Intracranial Dural Arteriovenous Fistulas in China
Role: collaborator
Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA
Role: lead
Effects of a Five-Dimensional Intervention Program Based on Inner Strength on Demoralization Syndrome in Elderly Cancer Patients
Role: lead
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer
Role: collaborator
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Role: lead
Artificial Intelligence for Rare Disease Diagnosis
Role: lead
CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA
Role: lead